In a story surveying a recent flurry of partnerships, buy-outs, and alliances among various pharmaceutical companies, entrepreneurs, and research labs, the Boston Globe spoke with Thayer School’s Tillman Gerngross about his efforts on behalf of his Lebanon, N.H.-based company Adimab LLC. Gerngross, a professor of engineering, was attending the 30th annual J.P. Morgan Healthcare Conference, held in early January in San Francisco.
“Pharmaceutical companies are tuning down their internal R&D,’’ said Gerngross, who, the Globe reported, booked business from Pfizer Inc., Merck & Co., Novartis AG, and other drug makers. “That’s very positive for companies like ours.’’
Read the full story, published 1/15/12 by The Boston Globe.
